{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:45:40Z","timestamp":1761561940679},"reference-count":30,"publisher":"Baishideng Publishing Group Inc.","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2005]]},"DOI":"10.3748\/wjg.v11.i12.1769","type":"journal-article","created":{"date-parts":[[2014,12,22]],"date-time":"2014-12-22T02:51:07Z","timestamp":1419216667000},"page":"1769","source":"Crossref","is-referenced-by-count":47,"title":["Psychiatric side effects of pegylated interferon alfa-2b as compared to conventional interferon alfa-2b in patients with chronic hepatitis C"],"prefix":"10.3748","volume":"11","author":[{"given":"Michael R","family":"Kraus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.323.7322.1141"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1007259"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Alter MJ. Epidemiology of hepatitis C. Hepatology 1997;26:62S-65S.","DOI":"10.1002\/hep.510260711"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200107053450107"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(02)80042-X"},{"key":"ref6","unstructured":"Hoofnagle JH. Chronic viral hepatitis C - clinical. Postgraduate Course, Chicago, 1998. Association for the study of liver diseases ."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)06102-5"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020047"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1176\/appi.psy.41.5.377"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200108023450514"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2002.01265.x"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n0614"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(03)00394-9"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1176\/appi.psy.44.2.104"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200012073432301"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Fried MW. Side effects of therapy of hepatitis C and their management. Hepatology 2002;36:S237-S244.","DOI":"10.1002\/hep.1840360730"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.3.425"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200161150-00013"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200321050-00005"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199811193392101"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Margraf J, Schneider S, Ehlers A. Diagnostisches interview bei psychischen störungen (german modified version of ADIS-R anxiety disorders interview schedule-revised; DiNardo PA, Barlow DH, 1988) Berlin: Springer; 1994;.","DOI":"10.1007\/978-3-662-06753-6"},{"key":"ref22","unstructured":"Diagnostic and statistical manual of mental disorders, fourth edition: DSM-IV. In: Association AP, ed. Washington D.C : American Psychiatric Association; 1994;."},{"key":"ref23","unstructured":"Herrmann C, Buss U, Snaith RP. HADS-D. Hospital Anxiety and Depression Scale - Deutsche Version. Ein fragebogen zur erfassung von angst und depressivität in der somatischen medizin Bern: Huber; 1995;."},{"key":"ref24","unstructured":"Franke GH. SCL-90-R Symptom-checkliste von derogatis deutsche version (testmappe mit handanweisung, 5 frageboegen, 5 auswertungsboegen und 5 boegen graphisches auswertungsschema). Symptom check list 90 items revised (Derogatis, L.R., 1977) - German version\/author Weinheim: Beltz; 1995;."},{"key":"ref25","unstructured":"Franke GH. SPSS für Windows 10.0.7 Chicago: SPSS Inc; 2000;."},{"key":"ref26","unstructured":"Valentine AD, Meyers CA, Kling MA, Richelson E, Hauser P. Mood and cognitive side effects of interferon-alpha therapy. Semin Oncol 1998;25:39-47."},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1159\/000051384"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(02)00264-1"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200202000-00014"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1023\/A:1011973823032"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v11\/i12\/1769.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,18]],"date-time":"2019-08-18T17:37:22Z","timestamp":1566149842000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v11\/i12\/1769.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.v11.i12.1769","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2005]]}}}